Functional properties of soluble CD21

被引:19
作者
Frémeaux-Bacchi, V
Kolb, JP
Rakotobé, S
Kazatchkine, MD
Fischer, EM
机构
[1] INSERM, U430, F-75014 Paris, France
[2] Univ Paris 06, Hop Broussais, F-75014 Paris, France
[3] Inst Curie, INSERM, U365, F-75048 Paris 05, France
来源
IMMUNOPHARMACOLOGY | 1999年 / 42卷 / 1-3期
关键词
soluble receptors; CD21; CD23; monocytes;
D O I
10.1016/S0162-3109(99)00026-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Soluble receptors may display immunoregulatory properties by blocking interactions between ligands and their membrane receptors or by triggering specific biologic responses through interaction with counter part membrane receptors. A natural soluble form of CD21 that is cleaved from lymphocyte membrane CD21 circulates in normal human serum. Soluble CD21 retains the capacity to bind iC3b and CD23, the known ligands of membrane CD21. In a similar fashion to IgE complexes, another ligand of CD23, the soluble CD21 was shown to efficiently trigger CD23-signalling pathways in human monocytes. By inducing release of proinflammatory cytokines and upregulating expression of molecules involved in antigen presentation, soluble CD21 modulates critical monocyte functions that may be relevant to allergic and inflammatory disorders. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 35 条
[1]   STRUCTURE AND FUNCTION OF THE COMPLEMENT RECEPTORS, CR-1 (CD35) AND CR-2 (CD21) [J].
AHEARN, JM ;
FEARON, DT .
ADVANCES IN IMMUNOLOGY, 1989, 46 :183-219
[2]  
AUBRY JP, 1994, J IMMUNOL, V152, P5806
[3]   CD21 IS A LIGAND FOR CD23 AND REGULATES IGE PRODUCTION [J].
AUBRY, JP ;
POCHON, S ;
GRABER, P ;
JANSEN, KU ;
BONNEFOY, JY .
NATURE, 1992, 358 (6386) :505-507
[4]   CD23 AND B-CELL ACTIVATION [J].
BONNEFOY, JY ;
LECOANETHENCHOZ, S ;
AUBRY, JP ;
GAUCHAT, JF ;
GRABER, P .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (03) :355-359
[5]  
BRADBURY LE, 1992, J IMMUNOL, V149, P2841
[6]   EPSTEIN-BARR-VIRUS (EBV) INDUCES EXPRESSION OF B-CELL ACTIVATION MARKERS ON INVITRO INFECTION OF EBV-NEGATIVE B-LYMPHOMA CELLS [J].
CALENDER, A ;
BILLAUD, M ;
AUBRY, JP ;
BANCHEREAU, J ;
VUILLAUME, M ;
LENOIR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8060-8064
[7]   Complement and the immune response [J].
Carroll, MC ;
Fischer, MB .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :64-69
[8]   CD19 - LOWERING THE THRESHOLD FOR ANTIGEN RECEPTOR STIMULATION OF LYMPHOCYTES-B [J].
CARTER, RH ;
FEARON, DT .
SCIENCE, 1992, 256 (5053) :105-107
[9]   STABLE TRANSFECTION OF EPSTEIN-BARR VIRUS (EBV) NUCLEAR ANTIGEN-2 IN LYMPHOMA-CELLS CONTAINING THE EBV-P3HR1 GENOME INDUCES EXPRESSION OF B-CELL ACTIVATION MOLECULES CD21 AND CD23 [J].
CORDIER, M ;
CALENDER, A ;
BILLAUD, M ;
ZIMBER, U ;
ROUSSELET, G ;
PAVLISH, O ;
BANCHEREAU, J ;
TURSZ, T ;
BORNKAMM, G ;
LENOIR, GM .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1002-1013
[10]  
DELESPESSE G, 1991, ADV IMMUNOL, V49, P149